| View |
|
DRHR-2129
|
Symclosene (Trichloroisocyanuric Acid)
|
Aquatabs Flo
|
15 grams per
|
Tablet
|
Water Disinfectant
|
Medentech Limited
|
Ireland
|
Renewal
|
03 May 2024
|
30 March 2029
|
| View |
DRP-7406-04_PI_01.pdf
|
DRP-7406-04
|
Metformin Hydrochloride
|
Neoform 500
|
500 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic
|
Hizon Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
22 March 2023
|
12 January 2027
|
| View |
DRP-12129-01_PI_01.pdf
|
DRP-12129-01
|
Meropenem (as trihydrate)
|
Merprofez 500
|
500 mg
|
Powder for Injection (I.V.)
|
Antibacterial (Carbapenem)
|
Mepromax Lifesciences Pvt. Ltd.
|
India
|
Renewal
|
24 March 2024
|
15 December 2029
|
| View |
DRP-12129-02_PI_01.pdf
|
DRP-12129-02
|
Meropenem (as trihydrate)
|
Morfenexx 500
|
500 mg
|
Powder for Injection (I.V.)
|
Antibacterial (Carbapenem)
|
Mepromax Lifesciences Pvt. Ltd
|
India
|
Renewal
|
07 April 2024
|
15 December 2029
|
| View |
DR-XY47705_PI_01.pdf
|
DR-XY47705
|
Rosuvastatin (As Zinc) + Ezetimibe
|
Rozuor
|
10 mg/10 mg
|
Capsule
|
Lipid Modifying Agent Combination
|
|
|
Monitored Release (Variation)
|
19 May 2023
|
04 February 2027
|
| View |
|
DRP-12977-01
|
Acetylcysteine
|
Acyden
|
600 mg
|
Powder for Oral Solution
|
Mucolytic
|
Hebei Tiancheng Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
29 May 2023
|
15 November 2027
|
| View |
|
DRP-12977-03
|
Acetylcysteine
|
Gosteine
|
600 mg
|
Powder for Oral Solution
|
Mucolytic
|
Hebei Tiancheng Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
06 February 2024
|
15 November 2027
|
| View |
|
DRP-12935-01
|
Acetylcysteine
|
Acyden
|
200 mg
|
Powder for Oral Solution
|
Mucolytic
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
17 June 2023
|
04 November 2027
|
| View |
|
DRP-12406-01
|
Ascorbic Acid + Zinc
|
Guico-C
|
500 mg (equivalent to 568.18 mg Sodium Ascorbate)/ 10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamin/Mineral
|
Kanion Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
01 August 2023
|
02 August 2027
|
| View |
|
DRP-8473-02
|
Ceftazidime (as Pentahydrate)
|
CEFTAZIDEN
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third Generation Cephalosporin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
Renewal
|
07 April 2024
|
15 July 2029
|
| View |
|
DRP-3601-8
|
Ceftriaxone Sodium
|
Goxone
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
CLIDP Conversion
|
19 February 2024
|
14 February 2029
|
| View |
|
DRP-12935-02
|
Acetylcysteine
|
Gosteine
|
200 mg
|
Powder for Oral Solution
|
Mucolytic
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
05 February 2024
|
04 November 2027
|
| View |
|
DRP-12933-01
|
Clindamycin (as phosphate)
|
Clindacure
|
150 mg/mL
|
Solution for Injection (IM/IV)
|
Antibacterial (Lincosamide)
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
|
CLIDP Conversion
|
02 February 2024
|
04 November 2027
|
| View |
|
DRP-12933-02
|
Clindamycin (as phosphate)
|
Godacyn C
|
150 mg/mL
|
Solution for Injection (IM/IV)
|
Antibacterial (Lincosamide)
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
06 February 2024
|
04 November 2027
|
| View |
|
DRP-12524-01
|
Furosemide
|
Furoden
|
10 mg/ mL
|
Solution for Injection (IM/IV)
|
Diuretic
|
Farbe Firma
|
India
|
CLIDP Conversion
|
07 February 2023
|
26 August 2027
|
| View |
|
DRP-13151-02
|
Hydrocortisone (as sodium succinate)
|
Efcortin
|
100 mg
|
Powder for Injection (I.M./I.V.)
|
Corticosteroid for Systemic Use (Glucocorticoid)
|
Skymap Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
29 May 2023
|
12 December 2027
|
| View |
|
DRP-9055-05
|
Meropenem (as trihydrate)
|
Merotech
|
1 g
|
Powder for Injection (IM/IV)
|
Beta-lactam Antibacterial (Carbapenem)
|
CSPC Ouyi Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
06 February 2024
|
31 October 2025
|
| View |
|
DRP-9055-04
|
Meropenem (as trihydrate)
|
Merocy
|
1 g
|
Powder for Injection (IM/IV)
|
Beta-lactam Antibacterial (Carbapenem)
|
CSPC Ouyi Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
22 January 2024
|
31 October 2025
|
| View |
|
DRP-13144-02
|
Norepinephrine (as bitartrate)
|
Norepiden
|
1 mg/mL (4 mg/ 4 mL)
|
Solution for Injection (IV)
|
Adrenergic/ Dopaminergic Agent
|
Farbe Firma Pvt. Ltd
|
India
|
CLIDP Conversion
|
14 February 2024
|
07 December 2027
|
| View |
|
DRP-8728-02
|
Paracetamol
|
PARACY
|
150 mg/mL
|
Solution for Infusion (IM/IV)
|
Analgesic/ Antipyretics
|
CSPC Ouyi Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
17 May 2024
|
30 July 2029
|